Pfizer will merge its Upjohn off-patent unit with Mylan to create a new US-based generics and biosimilars giant, the two companies have confirmed.
Pfizer To Merge Off-Patent Business With Mylan
Pfizer has announced plans to merge its off-patent unit with Mylan, creating a new generics and biosimilars giant in the US.
